NASDAQ:VBIO | Free Cash Flow | Valion Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.01M$7,000.00-$5.02M
2025-12-31-$2.29M$25,000.00-$2.31M
2025-03-31-$889,000.00$0.00-$889,000.00
2024-12-31-$1.37M$0.00-$1.37M
2024-03-31-$1.67M
2023-12-31-$1.77M$0.00-$1.77M
2023-03-31-$2.43M$94,000.00-$2.52M
2022-12-31-$2.23M$0.00-$2.23M
2022-03-31-$2.17M$6,000.00-$2.17M
2021-12-31-$2.76M
2021-03-31-$665,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7M$38,000.00-$7.04M
2024-12-31-$5.73M$0.00-$5.73M
2023-12-31-$8.51M$118,000.00-$8.63M
2022-12-31-$8.92M$11,000.00-$8.93M
2021-12-31-$5.61M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.